Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats
- 779 Downloads
The endocannabinoid system plays a crucial role in the control of emotionality and recent clinical findings have shown that heavy prenatal exposure to cannabis is significantly associated with self-reported anxiety symptoms in exposed children. However, the long-term neurobehavioral consequences of in utero exposure to low–moderate doses of cannabinoid compounds have never been investigated.
The objective of this study was to investigate whether perinatal exposure to moderate doses of the active constituent of cannabis, the CB1 cannabinoid receptor agonist delta-9-tetrahydrocannabinol (THC), influences the emotional reactivity of rat offspring.
Primiparous Wistar rats were treated during pregnancy and lactation with doses of THC equivalent to the current estimates of moderate cannabis consumption in humans (2.5–5 mg kg−1, per os, from gestational day 15 to postnatal day 9). The emotional reactivity of infant, adolescent, and adult offspring was investigated using the isolation-induced ultrasonic vocalization, social interaction, and elevated plus-maze tests, respectively.
Perinatal THC treatment did not affect parameters of reproduction; however, at the dose of 5 mg kg−1, it increased the number of ultrasounds emitted by rat pups removed from the nest, inhibited social interaction and play behavior in the adolescent offspring, and induced an anxiogenic-like profile in the adult offspring tested in the elevated plus-maze test.
These results suggest that the endocannabinoid system is involved in the control of emotionality since early developmental stages. Thus, even moderate doses of cannabinoid compounds, when administered during the perinatal period, can have profound consequences for brain maturation, leading to long-lasting neurodevelopmental alterations.
KeywordsTHC Marijuana Cannabis Pregnancy Lactation Anxiety Emotionality Ultrasonic vocalization Social interaction Elevated plus-maze
We thank Dr. L.J.M.J. Vanderschuren for critical reading of the manuscript and valuable suggestions and Daniela Valeri, Angela Saraceno, and Alessandra Sordi for technical help. This study was supported by grants PRIN 2005 (to M.R.C.), and FIRB 2006 (to V.C.) from Ministero dell’Università e della Ricerca Scientifica-Italy.
- Antonelli T, Tomasini MC, Tattoli M, Cassano T, Tanganelli S, Finetti S, Mazzoni E, Trabace L, Steardo L, Cuomo V, Ferraro L (2005) Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex 15:2013–2020PubMedCrossRefGoogle Scholar
- Branchi I, Santucci D, Alleva E (2006) Analysis of ultrasonic vocalizations emitted by infant rodents. In: Costa LG, Hodgson E, Lawrence DA, Reed DJ (eds) Current protocols in toxicology. Wiley, HobokenGoogle Scholar
- MacLean P (1990) The triune brain in evolution: role in paleocerebral functions. Plenum, New YorkGoogle Scholar
- Maier SE, Miller JA, Blackwell JM, West JR (1999) Fetal alcohol exposure and temporal vulnerability: regional differences in cell loss as a function of the timing of binge-like alcohol exposure during brain development. Alcohol Clin Exper Res 23:726–734Google Scholar
- Mereu G, Fa M, Ferraro L, Cagiano R, Antonelli T, Tattoli M, Ghiglieri V, Tanganelli S, Gessa GL, Cuomo V (2003) Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A 100:4915–4920PubMedCrossRefGoogle Scholar
- Michelsson K, Sirviö P, Wasz-Höckert O (1977) Sound spectrographic cry analysis of infants with bacterial meningitis. Dev Med Child Neurol 3:309–315Google Scholar
- Rodriguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 276:56–64PubMedGoogle Scholar